Since elevated levels of thyroid hormones, including T3, in obesity increase resting energy expenditure avoiding fat accumulation, one may speculate whether the administration of additional thyroid hormone can be used in pharmacological treatment of obesity. This evidence concerns the gene TG and obesity due to melanocortin 4 receptor deficiency.